
Opinion|Videos|May 29, 2024
Identifying the Most Impactful Disease Areas and Patient Populations for PDTs
Diana Brixner, PhD, highlights the potential for prescription digital therapeutics (PDTs) to have impact in areas such as facilitating behavioral change for mental health conditions and strengthening adherence for complex disease states with intricate drug regimens.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Diagnosing Alzheimer's Disease Agitation: Triggers, Care Specialties, and the Role of Primary Care
2
FDA Approves First Autoinjector for At-Home IV-Equivalent Diuresis
3
Defining Alzheimer's Disease Agitation: Diagnostic Criteria, Symptoms, and Disease Course
4
Small Workflow Changes Close Big Gaps in CKM Screening
5




